|
Index of reports
> Cases with Pyrexia (32)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mercaptopurine where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 32 Next >>
Possible Mercaptopurine side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient: male, weighing 63.5 kg (139.7 pounds)
Reactions: Night Sweats, Cellulitis, Hepatosplenic T-Cell Lymphoma, Pyrexia, Thirst, Laryngitis, Leukocytoclastic Vasculitis, Epstein-Barr Virus Infection, Fatigue, Sinus Headache, Bacterial Infection, Vision Blurred, Pharyngitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Remicade
Start date: 2000-06-16
Remicade
Start date: 2000-02-03
Remicade
Start date: 2003-01-06
Mercaptopurine
Dosage: 25mg am, 25mg pm
Indication: Crohn's Disease
Start date: 1999-11-01
End date: 2001-02-01
Mercaptopurine
Dosage: 25mg am, 25mg pm
Start date: 1998-05-01
Remicade
Start date: 2002-11-15
Remicade
Start date: 2002-09-27
Remicade
Start date: 1999-12-03
Remicade
Start date: 1999-09-01
Remicade
Start date: 2002-06-21
Mercaptopurine
Dosage: 25mg am, 25mg pm
Start date: 1997-12-01
Remicade
Indication: Crohn's Disease
Start date: 2000-08-17
Remicade
Start date: 2000-11-05
Remicade
Start date: 2002-08-09
Remicade
Start date: 2002-02-22
Remicade
Start date: 2002-02-11
Mercaptopurine
Dosage: 25mg am, 25mg pm
Start date: 1997-07-01
Other drugs received by patient: Prilosec; Azathioprine Sodium; Imuran; Prednisone TAB; Corticosteroids; Fosamax
Possible Mercaptopurine side effects in male
Reported by a physician from United Kingdom on 2012-08-21
Patient: male
Reactions: Pelvic Pain, Pyrexia, Anal Fistula, C-Reactive Protein Increased, Splenomegaly, Rectal Abscess, Lethargy, Hepatosplenic T-Cell Lymphoma, Crohn's Disease, Sepsis, Platelet Count Decreased, Diabetic Ketoacidosis, Neutropenia, Rectal Discharge, Leukopenia, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Indication: Crohn's Disease
Azathioprine Sodium
Dosage: 2.5 mg/kg
Indication: Crohn's Disease
Azathioprine Sodium
Start date: 2002-01-01
End date: 2006-09-01
Prednisolone
Indication: Product Used FOR Unknown Indication
Remicade
Indication: Crohn's Disease
End date: 2005-09-29
Azathioprine Sodium
Start date: 2001-06-01
Remicade
Dosage: stopped in february - march (3rd infusion)
End date: 2006-02-01
Other drugs received by patient: Metronidazole; Vitamin B-12
Possible Mercaptopurine side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-23
Patient: male, weighing 54.0 kg (118.8 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia, Chills, Anaemia, Febrile Neutropenia, Pyrexia, Oropharyngeal Pain, Fatigue, Respiratory Failure, Tachypnoea, Cough, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 135 mg
Methotrexate
Dosage: 270 mg
Mercaptopurine
Dosage: 8000 mg
Possible Mercaptopurine side effects in 17 year old female
Reported by a physician from United States on 2012-06-08
Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)
Reactions: Blood Bilirubin Increased, Pyrexia, Caecitis, Loss of Consciousness, Oedema Peripheral, Pulmonary Oedema, Hypocalcaemia, Acute Respiratory Distress Syndrome, Melaena, Hypertriglyceridaemia, Epistaxis, Dysphagia, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Eating Disorder, Tremor, Cerebral Infarction, Depressed Level of Consciousness, Neutropenia, Confusional State, Dyskinesia, Somnolence, Splenic Infarction, Hypokalaemia, Pleural Effusion, White Blood Cell Count Decreased, Cerebrovascular Accident, Ascites, Diarrhoea, Hypophagia, Hypoalbuminaemia, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Oncaspar
Indication: T-Cell Type Acute Leukaemia
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-04-13
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Dalteparin Sodium
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Nystatin; Lansoprazole; Insulin Aspart; Piperacillin and Tazobactam; Vancomycin; Voriconazole
Possible Mercaptopurine side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-25
Patient: female, weighing 14.9 kg (32.8 pounds)
Reactions: Anaemia, Hyponatraemia, Rash, Pyrexia, Ascites, Abdominal Pain Upper, Abdominal Compartment Syndrome, Respiratory Failure, Pneumonia Herpes Viral, Bone Marrow Failure, Neutropenia, Thrombocytopenia, Cardiac Arrest, Septic Shock, Infection in AN Immunocompromised Host
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: .99 mg
Methotrexate
Dosage: 24.5 mg
Dexamethasone
Dosage: 17.5 ml
Mercaptopurine
Dosage: 460 mg
Possible Mercaptopurine side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-25
Patient: female, weighing 14.9 kg (32.8 pounds)
Reactions: Coagulopathy, Hepatic Failure, Pyrexia, Abdominal Pain Upper, Laboratory Test Abnormal, Malaise, Bone Marrow Failure, Thrombocytopenia, Anaemia, Condition Aggravated, Hyponatraemia, Rash, Varicella, Abdominal Compartment Syndrome, Ascites, Respiratory Failure, Pneumonia Herpes Viral, Neutropenia, Immune System Disorder, Cardiac Arrest, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Dosage: 460 mg
Dexamethasone
Dosage: 17.5 mg
Vincristine Sulfate
Dosage: .99 mg
Methotrexate
Dosage: 24.5 mg
Possible Mercaptopurine side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-11
Patient: female, weighing 14.9 kg (32.8 pounds)
Reactions: Coagulopathy, Hepatic Failure, Pyrexia, Malaise, Bone Marrow Failure, Condition Aggravated, Hyponatraemia, Respiratory Distress, Abdominal Compartment Syndrome, Ascites, Respiratory Failure, Pneumonia Herpes Viral, Neutropenia, Lung Infiltration, Septic Shock, Cardiac Arrest
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: .99 mg
Methotrexate
Dosage: 24.5 mg
Dexamethasone
Dosage: 17.5 ml
Mercaptopurine
Dosage: 460 mg
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2012-04-26
Patient: female
Reactions: Gastrointestinal Bacterial Infection, Back Pain, Pain in Extremity, Pain of Skin, Injection Site Pain, Pyrexia, Hypoaesthesia, Paraesthesia, Diarrhoea, Bacterial Infection, Abdominal Distension, Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Indication: Product Used FOR Unknown Indication
Humira
Indication: Crohn's Disease
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2012-04-25
Patient: female
Reactions: Abdominal Pain, Hyperbilirubinaemia, Dyspnoea, Maternal Exposure During Pregnancy, Pyrexia, Abortion Spontaneous, Hyperhidrosis, Fibromyalgia, Arthralgia, Chest Pain, Pollakiuria, Dizziness, Demyelination
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Remicade
Dosage: four doses received
Indication: Crohn's Disease
Start date: 1999-08-25
Remicade
Start date: 2002-08-07
Mercaptopurine
Indication: Crohn's Disease
Remicade
Start date: 2003-06-12
End date: 2003-01-01
Remicade
Start date: 2002-10-04
Possible Mercaptopurine side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-24
Patient: female, weighing 90.8 kg (199.8 pounds)
Reactions: Gastrointestinal Bacterial Infection, Back Pain, Pancreas Infection, Pain in Extremity, Injection Site Pain, Hypoaesthesia, Pyrexia, Paraesthesia, Diarrhoea, Sensory Disturbance, Pancreatitis, Abdominal Distension, Tenderness, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humira
Start date: 2010-03-01
Humira
Indication: Crohn's Disease
Start date: 2009-01-01
End date: 2010-01-01
Mercaptopurine
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Slow FE; Levothyroxine Sodium; Zyrtec; Multi-Vitamin; Prilosec
Possible Mercaptopurine side effects in female
Reported by a consumer/non-health professional from Netherlands on 2012-04-20
Patient: female, weighing 58.8 kg (129.4 pounds)
Reactions: Post Transplant Lymphoproliferative Disorder, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 15 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-08
End date: 2010-06-08
Methotrexate
Dosage: 17.5 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-03-03
End date: 2011-03-30
Methotrexate
Dosage: 15 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-09-15
End date: 2011-10-13
Methotrexate
Dosage: 15 mg, qd (days 1, 8 and 15)
Administration route: Oral
Start date: 2011-10-14
End date: 2011-11-20
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-03-03
End date: 2011-03-30
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-08-18
End date: 2011-09-14
Prednisone TAB
Dosage: 50 mg, qd
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
End date: 2010-05-17
Prednisone TAB
Dosage: 35 mg, qd
Administration route: Oral
Start date: 2010-05-18
End date: 2010-06-14
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-02-03
End date: 2011-03-02
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-03-03
End date: 2011-03-30
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-22
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-07-21
End date: 2011-08-17
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-08-18
End date: 2011-09-14
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2010-12-09
End date: 2010-12-09
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-03-03
End date: 2011-03-03
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-09-15
End date: 2011-09-15
Cytarabine
Dosage: 310 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-20
End date: 2010-06-20
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-11-18
End date: 2010-11-18
Methotrexate
Dosage: 17.5 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2010-12-09
End date: 2011-01-05
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-27
Mercaptopurine
Dosage: 90 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-01-06
End date: 2011-02-02
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-27
PEG-Asparaginase
Dosage: 1575 iu, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-09-25
End date: 2010-09-25
Doxorubicin HCL
Dosage: 62 mg, qd
Start date: 2010-08-18
End date: 2010-08-18
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-01-06
End date: 2011-02-02
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-27
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-04-28
End date: 2011-05-25
Vincristine
Dosage: 1 mg, qd
Start date: 2010-08-19
End date: 2010-08-19
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-02-03
End date: 2011-02-03
Methotrexate
Dosage: 775 mg, qd
Start date: 2010-06-23
End date: 2010-06-23
Mercaptopurine
Dosage: 75 mg, qd, days 0-27
Administration route: Oral
Start date: 2010-12-09
End date: 2011-01-05
Etoposide
Dosage: 188 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-20
End date: 2010-06-20
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-06-23
End date: 2011-07-20
Vincristine
Dosage: 1 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-18
End date: 2010-05-18
Vincristine
Dosage: 1 mg, qd
Start date: 2010-05-25
End date: 2010-05-25
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2010-11-11
End date: 2010-11-11
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-07-21
End date: 2011-07-21
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-08-18
End date: 2011-08-18
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-07-23
End date: 2010-07-23
Cytarabine
Dosage: 3140 mg, qd
Start date: 2010-09-23
End date: 2010-09-24
Evoltra
Dosage: 33 mg, qdx5
Start date: 2010-07-20
End date: 2010-07-24
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-06-23
End date: 2011-07-20
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-07-21
End date: 2011-08-17
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-22
Mercaptopurine
Dosage: 100 mg, qd (days 1-28)
Administration route: Oral
Start date: 2011-10-14
End date: 2011-11-20
Mercaptopurine
Dosage: 50 mg, once
Administration route: Oral
Start date: 2012-01-12
End date: 2012-01-12
Dexamethasone
Dosage: 4 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-08
End date: 2010-06-08
Doxorubicin HCL
Dosage: 62 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Doxorubicin HCL
Dosage: 62 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-03-31
End date: 2011-03-31
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-04-28
End date: 2011-04-28
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-05-26
End date: 2011-05-26
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-06-23
End date: 2011-06-23
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-12-09
End date: 2010-12-09
Cytarabine
Dosage: 80 mg, qd
Start date: 2011-02-03
End date: 2011-02-03
Methotrexate
Dosage: 20 mg, qd (days 1, 8 and 15)
Administration route: Oral
Start date: 2011-11-21
Methotrexate
Dosage: 15 mg, once
Administration route: Oral
Start date: 2012-01-12
End date: 2012-01-12
Mercaptopurine
Dosage: 100 mg, qd, days 0-27
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-11-11
End date: 2010-12-08
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-06-23
End date: 2011-07-20
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-07-30
End date: 2010-07-30
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Dexamethasone
Dosage: 4 mg, qd
Start date: 2011-02-03
End date: 2011-02-03
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2010-12-09
End date: 2011-01-05
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-09-15
End date: 2011-10-13
Methotrexate
Dosage: 25 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2010-11-11
End date: 2010-12-08
Methotrexate
Dosage: 17.5 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-01-06
End date: 2011-02-02
Mercaptopurine
Dosage: 100 mg, qd (days 1-28)
Administration route: Oral
Start date: 2011-11-21
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-07-23
End date: 2010-07-23
Doxorubicin HCL
Dosage: 66 mg, qd
Start date: 2010-06-01
End date: 2010-06-01
Vincristine
Dosage: 1 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Evoltra
Dosage: 33 mg, qdx5
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
End date: 2010-05-15
Methotrexate
Dosage: 775 mg, qd
Start date: 2010-06-30
End date: 2010-06-30
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-04-28
End date: 2011-05-25
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-08-18
End date: 2011-09-14
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-02-03
End date: 2011-03-02
Etoposide
Dosage: 188 mg, qd
Start date: 2010-06-27
End date: 2010-06-27
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-11-18
End date: 2010-11-18
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-12-09
End date: 2010-12-09
Vincristine
Dosage: 1 mg, qd
Start date: 2010-06-01
End date: 2010-06-01
Vincristine
Dosage: 1 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-01-06
End date: 2011-01-06
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-07-30
End date: 2010-07-30
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-22
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-04-28
End date: 2011-05-25
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-07-21
End date: 2011-08-17
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-09-15
End date: 2011-10-13
PEG-Asparaginase
Dosage: 1575 iu, qd
Start date: 2010-10-10
End date: 2010-10-10
Doxorubicin HCL
Dosage: 66 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-25
End date: 2010-05-25
Prednisone TAB
Dosage: 60 mg, qd
Administration route: Oral
Start date: 2010-08-19
End date: 2010-09-16
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2010-11-11
End date: 2010-12-08
Cytarabine
Dosage: 310 mg, qd
Start date: 2010-06-27
End date: 2010-06-27
Possible Mercaptopurine side effects in 76 year old male
Reported by a consumer/non-health professional from United States on 2012-04-16
Patient: 76 year old male, weighing 79.4 kg (174.6 pounds)
Reactions: Renal Failure, Activities of Daily Living Impaired, Pyrexia, Headache, Asthenia
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Mercaptopurine
Possible Mercaptopurine side effects in female
Reported by a physician from Netherlands on 2012-03-16
Patient: female, weighing 58.8 kg (129.4 pounds)
Reactions: Post Transplant Lymphoproliferative Disorder, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 15 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-08
End date: 2010-06-08
Methotrexate
Dosage: 775 mg, qd
Start date: 2010-06-30
End date: 2010-06-30
Methotrexate
Dosage: 15 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-09-15
End date: 2011-10-13
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-08-18
End date: 2011-09-14
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-07-30
End date: 2010-07-30
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-04-28
End date: 2011-05-25
Vincristine
Dosage: 1 mg, qd
Start date: 2010-05-25
End date: 2010-05-25
Cytarabine
Dosage: 310 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-20
End date: 2010-06-20
Evoltra
Dosage: 33 mg, qdx5
Start date: 2010-07-20
End date: 2010-07-24
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-08-18
End date: 2011-09-14
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-02-03
End date: 2011-03-02
Mercaptopurine
Dosage: 100 mg, qd (days 1-28)
Administration route: Oral
Start date: 2011-10-14
End date: 2011-11-20
Doxorubicin HCL
Dosage: 66 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-25
End date: 2010-05-25
Prednisone TAB
Dosage: 60 mg, qd
Administration route: Oral
Start date: 2010-08-19
End date: 2010-09-16
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-03-03
End date: 2011-03-30
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-27
Vincristine
Dosage: 1 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-18
End date: 2010-05-18
Vincristine
Dosage: 1 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-01-06
End date: 2011-01-06
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-04-28
End date: 2011-04-28
Methotrexate
Dosage: 17.5 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-03-03
End date: 2011-03-30
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-07-21
End date: 2011-08-17
Mercaptopurine
Dosage: 100 mg, qd, days 0-27
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-11-11
End date: 2010-12-08
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-27
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-04-28
End date: 2011-05-25
Mercaptopurine
Dosage: 100 mg, qd (days 1-28)
Administration route: Oral
Start date: 2011-11-21
End date: 2012-01-12
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-07-23
End date: 2010-07-23
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-01-06
End date: 2011-02-02
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-06-23
End date: 2011-07-20
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-07-21
End date: 2011-08-17
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-05-26
End date: 2011-05-26
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-07-30
End date: 2010-07-30
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-11-18
End date: 2010-11-18
Methotrexate
Dosage: 17.5 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-01-06
End date: 2011-02-02
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-04-28
End date: 2011-05-25
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-22
Mercaptopurine
Dosage: 75 mg, qd, days 0-27
Administration route: Oral
Start date: 2010-12-09
End date: 2011-01-05
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-06-23
End date: 2011-07-20
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-09-15
End date: 2011-10-13
Doxorubicin HCL
Dosage: 62 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2010-11-11
End date: 2010-12-08
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2010-12-09
End date: 2011-01-05
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-08-18
End date: 2011-09-14
Vincristine
Dosage: 1 mg, qd
Start date: 2010-08-19
End date: 2010-08-19
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2010-12-09
End date: 2010-12-09
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-07-21
End date: 2011-07-21
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-08-18
End date: 2011-08-18
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-07-23
End date: 2010-07-23
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-12-09
End date: 2010-12-09
Methotrexate
Dosage: 25 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2010-11-11
End date: 2010-12-08
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-22
Vincristine
Dosage: 1 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Methotrexate
Dosage: 15 mg, qd (days 1, 8 and 15)
Administration route: Oral
Start date: 2011-10-14
End date: 2011-11-20
Etoposide
Dosage: 188 mg, qd
Start date: 2010-06-27
End date: 2010-06-27
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
PEG-Asparaginase
Dosage: 1575 iu, qd
Start date: 2010-10-10
End date: 2010-10-10
Doxorubicin HCL
Dosage: 66 mg, qd
Start date: 2010-06-01
End date: 2010-06-01
Doxorubicin HCL
Dosage: 62 mg, qd
Start date: 2010-08-18
End date: 2010-08-18
Vincristine
Dosage: 1 mg, qd
Start date: 2010-06-01
End date: 2010-06-01
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-02-03
End date: 2011-02-03
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-03-31
End date: 2011-03-31
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-06-23
End date: 2011-06-23
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-09-15
End date: 2011-09-15
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Evoltra
Dosage: 33 mg, qdx5
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
End date: 2010-05-15
Methotrexate
Dosage: 775 mg, qd
Start date: 2010-06-23
End date: 2010-06-23
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-06-23
End date: 2011-07-20
Methotrexate
Dosage: 20 mg, qd (days 1, 8 and 15)
Administration route: Oral
Start date: 2011-11-21
End date: 2012-01-12
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-07-21
End date: 2011-08-17
Etoposide
Dosage: 188 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-20
End date: 2010-06-20
Dexamethasone
Dosage: 4 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-08
End date: 2010-06-08
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-11-18
End date: 2010-11-18
Dexamethasone
Dosage: 4 mg, qd
Start date: 2011-02-03
End date: 2011-02-03
PEG-Asparaginase
Dosage: 1575 iu, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-09-25
End date: 2010-09-25
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-02-03
End date: 2011-03-02
Cytarabine
Dosage: 3140 mg, qd
Start date: 2010-09-23
End date: 2010-09-24
Cytarabine
Dosage: 80 mg, qd
Start date: 2011-02-03
End date: 2011-02-03
Methotrexate
Dosage: 17.5 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2010-12-09
End date: 2011-01-05
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-27
Mercaptopurine
Dosage: 90 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-01-06
End date: 2011-02-02
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-03-03
End date: 2011-03-30
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-22
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-12-09
End date: 2010-12-09
Doxorubicin HCL
Dosage: 62 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Prednisone TAB
Dosage: 50 mg, qd
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
End date: 2010-05-17
Prednisone TAB
Dosage: 35 mg, qd
Administration route: Oral
Start date: 2010-05-18
End date: 2010-06-14
Prednisone TAB
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-09-15
End date: 2011-10-13
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2010-11-11
End date: 2010-11-11
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-03-03
End date: 2011-03-03
Cytarabine
Dosage: 310 mg, qd
Start date: 2010-06-27
End date: 2010-06-27
Possible Mercaptopurine side effects in female
Reported by a consumer/non-health professional from Netherlands on 2012-03-09
Patient: female, weighing 58.8 kg (129.4 pounds)
Reactions: Post Transplant Lymphoproliferative Disorder, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 25 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2010-11-11
End date: 2010-12-08
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-27
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-04-28
End date: 2011-05-25
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-08-18
End date: 2011-09-14
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-22
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-08-18
End date: 2011-09-14
Doxorubicin HCL
Dosage: 62 mg, qd
Start date: 2010-08-18
End date: 2010-08-18
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2010-12-09
End date: 2011-01-05
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-02-03
End date: 2011-03-02
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-03-03
End date: 2011-03-30
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-06-23
End date: 2011-07-20
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-07-21
End date: 2011-08-17
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-05-26
End date: 2011-05-26
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-09-15
End date: 2011-09-15
Cytarabine
Dosage: 310 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-20
End date: 2010-06-20
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-09-15
End date: 2011-10-13
Dexamethasone
Dosage: 4 mg, qd
Start date: 2011-02-03
End date: 2011-02-03
Doxorubicin HCL
Dosage: 62 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-01-06
End date: 2011-02-02
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-27
Vincristine
Dosage: 1 mg, qd
Start date: 2010-05-25
End date: 2010-05-25
Vincristine
Dosage: 1 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-03-31
End date: 2011-03-31
Cytarabine
Dosage: 310 mg, qd
Start date: 2010-06-27
End date: 2010-06-27
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Methotrexate
Dosage: 775 mg, qd
Start date: 2010-06-30
End date: 2010-06-30
Methotrexate
Dosage: 15 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-09-15
End date: 2011-10-13
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-07-21
End date: 2011-08-17
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-12-09
End date: 2010-12-09
Prednisone
Dosage: 60 mg, qd
Administration route: Oral
Start date: 2010-08-19
End date: 2010-09-16
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-04-28
End date: 2011-05-25
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-08-18
End date: 2011-09-14
Vincristine
Dosage: 1 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2010-11-11
End date: 2010-11-11
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-03-03
End date: 2011-03-03
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-08-18
End date: 2011-08-18
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-07-30
End date: 2010-07-30
Methotrexate
Dosage: 15 mg, qd once a week
Administration route: Oral
Start date: 2011-10-14
End date: 2011-11-20
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-07-23
End date: 2010-07-23
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-09-02
End date: 2010-09-02
Doxorubicin HCL
Dosage: 66 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-25
End date: 2010-05-25
Prednisone
Dosage: 35 mg, qd
Administration route: Oral
Start date: 2010-05-18
End date: 2010-06-14
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-09-15
End date: 2011-10-13
Vincristine
Dosage: 1 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-18
End date: 2010-05-18
Methotrexate
Dosage: 17.5 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-03-03
End date: 2011-03-30
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-04-28
End date: 2011-05-25
Cytarabine
Dosage: 3140 mg, qd
Start date: 2010-09-23
End date: 2010-09-24
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-12-09
End date: 2010-12-09
Cytarabine
Dosage: 80 mg, qd
Start date: 2011-02-03
End date: 2011-02-03
Evoltra
Dosage: 33 mg, qdx5
Start date: 2010-07-20
End date: 2010-07-24
Methotrexate
Dosage: 775 mg, qd
Start date: 2010-06-23
End date: 2010-06-23
Methotrexate
Dosage: 17.5 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-01-06
End date: 2011-02-02
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-06-23
End date: 2011-07-20
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-03-03
End date: 2011-03-30
Mercaptopurine
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2011-11-21
End date: 2012-01-12
Etoposide
Dosage: 188 mg, qd
Start date: 2010-06-27
End date: 2010-06-27
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-11-18
End date: 2010-11-18
PEG-Asparaginase
Dosage: 1575 iu, qd
Start date: 2010-10-10
End date: 2010-10-10
Prednisone
Dosage: 50 mg, qd
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
End date: 2010-05-17
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2010-12-09
End date: 2010-12-09
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-01-06
End date: 2011-01-06
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-02-03
End date: 2011-02-03
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-04-28
End date: 2011-04-28
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-06-23
End date: 2011-06-23
Evoltra
Dosage: 33 mg, qdx5
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
End date: 2010-05-15
Methotrexate
Dosage: 17.5 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2010-12-09
End date: 2011-01-05
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-22
Mercaptopurine
Dosage: 100 mg, qd, days 0-27
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-11-11
End date: 2010-12-08
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-27
Etoposide
Dosage: 188 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-20
End date: 2010-06-20
PEG-Asparaginase
Dosage: 1575 iu, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-09-25
End date: 2010-09-25
Doxorubicin HCL
Dosage: 66 mg, qd
Start date: 2010-06-01
End date: 2010-06-01
Doxorubicin HCL
Dosage: 62 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Vincristine
Dosage: 1 mg, qd
Start date: 2010-06-01
End date: 2010-06-01
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-07-23
End date: 2010-07-23
Methotrexate
Dosage: 15 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-08
End date: 2010-06-08
Methotrexate
Dosage: 20 mg, qd on day 7, 14, 21
Administration route: Oral
Start date: 2011-07-21
End date: 2011-08-17
Methotrexate
Dosage: 20 mg, qd once a week
Administration route: Oral
Start date: 2011-11-21
End date: 2012-01-12
Mercaptopurine
Dosage: 75 mg, qd, days 0-27
Administration route: Oral
Start date: 2010-12-09
End date: 2011-01-05
Mercaptopurine
Dosage: 90 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-01-06
End date: 2011-02-02
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-02-03
End date: 2011-03-02
Mercaptopurine
Dosage: 50 mg, qd, days 0-27
Administration route: Oral
Start date: 2011-06-23
End date: 2011-07-20
Mercaptopurine
Dosage: 100 mg, qd
Administration route: Oral
Start date: 2011-10-14
End date: 2011-11-20
Dexamethasone
Dosage: 4 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-08
End date: 2010-06-08
Dexamethasone
Dosage: 4 mg, qd
Start date: 2010-07-30
End date: 2010-07-30
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2010-11-11
End date: 2010-12-08
Prednisone
Dosage: 55 mg, qd, days 0-6
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-22
Vincristine
Dosage: 1 mg, qd
Start date: 2010-08-19
End date: 2010-08-19
Vincristine
Dosage: 2 mg, qd, day 1 of every month
Start date: 2011-07-21
End date: 2011-07-21
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-08-26
End date: 2010-08-26
Cytarabine
Dosage: 80 mg, qd
Start date: 2010-11-18
End date: 2010-11-18
Possible Mercaptopurine side effects in female
Reported by a physician from Switzerland on 2012-02-20
Patient: female
Reactions: Pancytopenia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Trisenox
Start date: 2009-01-29
Atracurium Besylate
Administration route: Oral
Start date: 2009-06-18
End date: 2009-07-02
Trisenox
Start date: 2009-04-08
Methotrexate
Administration route: Oral
Start date: 2009-06-18
End date: 2009-07-09
Mercaptopurine
Administration route: Oral
Start date: 2009-06-18
End date: 2009-07-11
Other drugs received by patient: Amikin; Levofloxacin; Nopil Forte; Cefepime; Cefepime; Nopil Forte; Cefepime; Bactrim DS; Levofloxacin
Possible Mercaptopurine side effects in 63 year old male
Reported by a pharmacist from United States on 2012-02-17
Patient: 63 year old male
Reactions: Myalgia, Night Sweats, Headache, Pyrexia
Drug(s) suspected as cause:
Mercaptopurine
Possible Mercaptopurine side effects in female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-02-14
Patient: female, weighing 58.8 kg (129.4 pounds)
Reactions: Post Transplant Lymphoproliferative Disorder, Pyrexia
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Evoltra
Dosage: 33 mg, unk
Start date: 2011-07-20
End date: 2011-07-24
Mercaptopurine
Dosage: 50 mg, qd
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-12
End date: 2012-01-12
Methotrexate
Dosage: 15 mg, qw
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-12
End date: 2012-01-12
Evoltra
Dosage: 33 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
Possible Mercaptopurine side effects in female
Reported by a physician from Netherlands on 2012-02-07
Patient: female, weighing 58.8 kg (129.4 pounds)
Reactions: Post Transplant Lymphoproliferative Disorder, Pyrexia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Methotrexate
Dosage: 15 mg, qw
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-12
End date: 2012-01-12
Mercaptopurine
Dosage: 50 mg, qd
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-12
End date: 2012-01-12
Evoltra
Dosage: 33 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
End date: 2010-07-24
Possible Mercaptopurine side effects in 9 year old female
Reported by a physician from United States on 2012-01-30
Patient: 9 year old female, weighing 39.4 kg (86.7 pounds)
Reactions: Tachycardia, Pulmonary Embolism, Pyrexia, Constipation, Somnolence, Hypokalaemia, Partial Seizures, Sinusitis, Blepharospasm, Atrial Thrombosis, Hypotension, Cerebral Atrophy, Rash, Varicella Virus Test Positive, Tremor, Haemoglobin Decreased, Fungal Infection, Bacteraemia, Lacunar Infarction, Hypoalbuminaemia, Platelet Count Decreased, Neutropenia, Seizure Like Phenomena
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg, 3x/day, subuctaneous; 100 mg once, subcutaneous
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-06-07
End date: 2011-06-10
Cytarabine
Dosage: 100 mg, 3x/day, subuctaneous; 100 mg once, subcutaneous
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-06-13
End date: 2011-06-16
Vincristine Sulfate
Dosage: 2 mg, weekly, intravenous; 1.9 mg, single, intravenous
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-04-08
End date: 2011-04-29
Vincristine Sulfate
Dosage: 2 mg, weekly, intravenous; 1.9 mg, single, intravenous
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-06-20
End date: 2011-06-20
*peg-Asparaginase (Asparaginase) Unknown
Dosage: 3150 iu, single, intramuscular
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-06-20
End date: 2011-06-20
Methotrexate
Dosage: see image
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-06-06
End date: 2011-06-06
Methotrexate
Dosage: see image
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-06-13
End date: 2011-06-13
Methotrexate
Dosage: see image
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-05-06
End date: 2011-05-06
Methotrexate
Dosage: see image
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-06-20
End date: 2011-06-20
Methotrexate
Dosage: see image
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-04-15
End date: 2011-04-15
Dalteparin Sodium
Dosage: 5395 iu, 2x/day, subcutaneous; 5395 iu, 2x/day, subcutaneous
Indication: Pulmonary Embolism
Start date: 2011-05-13
End date: 2011-06-26
Dalteparin Sodium
Dosage: 5395 iu, 2x/day, subcutaneous; 5395 iu, 2x/day, subcutaneous
Indication: Atrial Thrombosis
Start date: 2011-05-13
End date: 2011-06-26
Dalteparin Sodium
Dosage: 5395 iu, 2x/day, subcutaneous; 5395 iu, 2x/day, subcutaneous
Indication: Pulmonary Embolism
Start date: 2011-06-27
Dalteparin Sodium
Dosage: 5395 iu, 2x/day, subcutaneous; 5395 iu, 2x/day, subcutaneous
Indication: Atrial Thrombosis
Start date: 2011-06-27
Cyclophosphamide
Dosage: 1300 mg single, intravenous; 100mg once, subcutaneous
Start date: 2011-06-06
End date: 2011-06-06
Mercaptopurine
Dosage: 75 mg, once daily six days per week, oral; 100 mg, once per day on seventh day of week, oral
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-06-06
End date: 2011-06-19
Mercaptopurine
Dosage: 75 mg, once daily six days per week, oral; 100 mg, once per day on seventh day of week, oral
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-06-06
End date: 2011-06-19
Other drugs received by patient: Zofran; Bactrim; Sodium Chloride 0.9%; Heparin; Ranitidine Hydrochloride; Emla; Acetaminophen
Possible Mercaptopurine side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-28
Patient: female
Reactions: Pyrexia
Drug(s) suspected as cause:
Mercaptopurine
Indication: Product Used FOR Unknown Indication
Humira
Indication: Product Used FOR Unknown Indication
Possible Mercaptopurine side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-20
Patient: male, weighing 63.5 kg (139.7 pounds)
Reactions: Night Sweats, Cellulitis, Hepatosplenic T-Cell Lymphoma, Pyrexia, Thirst, Laryngitis, Leukocytoclastic Vasculitis, Epstein-Barr Virus Infection, Fatigue, Sinus Headache, Bacterial Infection, Vision Blurred, Pharyngitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Remicade
Indication: Crohn's Disease
Start date: 2000-08-17
Remicade
Start date: 2000-11-05
Remicade
Start date: 2000-02-03
Remicade
Start date: 2002-06-21
Mercaptopurine
Dosage: 25mg am, 25mg pm
Indication: Crohn's Disease
Start date: 1999-11-01
End date: 2001-02-01
Mercaptopurine
Dosage: 25mg am, 25mg pm
Start date: 1997-07-01
Remicade
Start date: 2003-01-06
Remicade
Start date: 1999-12-03
Remicade
Start date: 2000-06-16
Mercaptopurine
Dosage: 25mg am, 25mg pm
Start date: 1997-12-01
Remicade
Start date: 2002-09-27
Remicade
Start date: 2002-11-15
Remicade
Start date: 2002-02-11
Mercaptopurine
Dosage: 25mg am, 25mg pm
Start date: 1998-05-01
Remicade
Start date: 1999-09-01
Remicade
Start date: 2002-02-22
Remicade
Start date: 2002-08-09
Other drugs received by patient: Prednisone; Imuran; Prilosec; Azathioprine; Fosamax; Corticosteroids
Possible Mercaptopurine side effects in male
Reported by a individual with unspecified qualification from United States on 2011-12-20
Patient: male, weighing 76.4 kg (168.1 pounds)
Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia, Leukaemia Recurrent
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 50 mg
Vincristine Sulfate
Dosage: 2 mg
Dexamethasone
Dosage: 50 mg
Mercaptopurine
Dosage: 1150 mg
Possible Mercaptopurine side effects in 29 year old female
Reported by a physician from United States on 2011-12-09
Patient: 29 year old female
Reactions: Pneumonia Legionella, Dyspnoea, Crohn's Disease, Atrial Fibrillation, Pyrexia, Peripheral Embolism, Fungal Infection, Dehydration, Acute Respiratory Distress Syndrome, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Remicade
Indication: Crohn's Disease
Start date: 1999-01-06
End date: 1999-01-06
Mercaptopurine
Indication: Product Used FOR Unknown Indication
Prednisone
Indication: Product Used FOR Unknown Indication
End date: 1999-01-24
Other drugs received by patient: Hydromorphone HCL; Calcium Channel Blocker; Levofloxacin; Azathioprine; Methadone HCL; Digoxin; Erythromycin; Atenolol; Adenosine; Mesalamine
Possible Mercaptopurine side effects in male
Reported by a physician from United States on 2011-11-18
Patient: male, weighing 47.6 kg (104.7 pounds)
Reactions: Pain, Pyrexia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 888 mg
Cyclophosphamide
Dosage: 1480 mg
Mercaptopurine
Dosage: 1246 mg
Vincristine Sulfate
Dosage: 4 mg
Possible Mercaptopurine side effects in male
Reported by a physician from United States on 2011-11-07
Patient: male, weighing 80.5 kg (177.1 pounds)
Reactions: Multi-Organ Failure, Abdominal Pain, Renal Impairment, Dialysis, Liver Function Test Abnormal, Portal Vein Thrombosis, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 52.5 mg
Dexamethasone Sodium Phosphate
Dosage: 2 mg
Methotrexate
Dosage: 15 mg
Mercaptopurine
Dosage: 450 mg
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2011-11-04
Patient: female
Reactions: Abdominal Pain, Hyperbilirubinaemia, Dyspnoea, Maternal Exposure During Pregnancy, Pyrexia, Hyperhidrosis, Abortion Spontaneous, Arthralgia, Fibromyalgia, Chest Pain, Dizziness, Pollakiuria, Demyelination
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Remicade
Start date: 2002-08-07
Remicade
Dosage: four doses received
Indication: Crohn's Disease
Start date: 1999-08-25
Remicade
Start date: 2003-06-12
End date: 2003-01-01
Remicade
Start date: 2002-10-04
Mercaptopurine
Indication: Crohn's Disease
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2011-10-19
Patient: female
Reactions: Abdominal Pain, Dyspnoea, Hyperbilirubinaemia, Maternal Exposure During Pregnancy, Pyrexia, Abortion Spontaneous, Hyperhidrosis, Fibromyalgia, Arthralgia, Chest Pain, Dizziness, Pollakiuria, Demyelination
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Remicade
Start date: 2002-08-07
Remicade
Start date: 2003-06-12
End date: 2003-01-01
Mercaptopurine
Indication: Crohn's Disease
Remicade
Start date: 2002-10-04
Remicade
Dosage: four doses received
Indication: Crohn's Disease
Start date: 1999-08-25
Possible Mercaptopurine side effects in male
Reported by a physician from United Kingdom on 2011-10-14
Patient: male
Reactions: Pyrexia, Pelvic Pain, Anal Fistula, C-Reactive Protein Increased, Splenomegaly, Rectal Abscess, Lethargy, Crohn's Disease, Hepatosplenic T-Cell Lymphoma, Sepsis, Platelet Count Decreased, Neutropenia, Diabetic Ketoacidosis, Rectal Discharge, Leukopenia, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Azathioprine
Start date: 2002-01-01
End date: 2006-09-01
Remicade
Indication: Crohn's Disease
End date: 2005-09-29
Prednisolone
Indication: Ill-Defined Disorder
Mercaptopurine
Indication: Crohn's Disease
Azathioprine
Dosage: 2.5 mg/kg
Indication: Crohn's Disease
Remicade
Dosage: stopped in february - march (3rd infusion)
End date: 2006-02-01
Azathioprine
Start date: 2001-06-01
Other drugs received by patient: Metronidazole; VIT B12
Possible Mercaptopurine side effects in male
Reported by a physician from United States on 2011-10-14
Patient: male, weighing 63.5 kg (139.7 pounds)
Reactions: Night Sweats, Cellulitis, Hepatosplenic T-Cell Lymphoma, Thirst, Pyrexia, Laryngitis, Epstein-Barr Virus Infection, Leukocytoclastic Vasculitis, Fatigue, Sinus Headache, Vision Blurred, Bacterial Infection, Pharyngitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Remicade
Start date: 2002-11-15
Remicade
Start date: 2003-01-06
Remicade
Start date: 2000-02-03
Remicade
Start date: 2000-06-16
Remicade
Start date: 1999-09-01
Remicade
Start date: 1999-12-03
Remicade
Start date: 2002-02-11
Remicade
Start date: 2002-08-09
Remicade
Start date: 2002-02-22
Mercaptopurine
Dosage: 25mg am, 25mg pm
Start date: 1998-05-01
Mercaptopurine
Dosage: 25mg am, 25mg pm
Start date: 1997-12-01
Remicade
Indication: Crohn's Disease
Start date: 2000-08-17
Remicade
Start date: 2002-09-27
Remicade
Start date: 2002-06-21
Mercaptopurine
Dosage: 25mg am, 25mg pm
Indication: Crohn's Disease
Start date: 1999-11-01
End date: 2001-02-01
Remicade
Start date: 2000-11-05
Mercaptopurine
Dosage: 25mg am, 25mg pm
Start date: 1997-07-01
Other drugs received by patient: Fosamax; Prilosec; Prednisone; Steroids; Imuran; Azathioprine
Possible Mercaptopurine side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-14
Patient: female
Reactions: Abdominal Pain, Dyspnoea, Hyperbilirubinaemia, Maternal Exposure During Pregnancy, Pyrexia, Abortion Spontaneous, Hyperhidrosis, Arthralgia, Fibromyalgia, Chest Pain, Dizziness, Pollakiuria, Demyelination
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Remicade
Start date: 2003-06-12
End date: 2003-01-01
Remicade
Start date: 2002-08-07
Remicade
Dosage: four doses received
Indication: Crohn's Disease
Start date: 1999-08-25
Mercaptopurine
Indication: Crohn's Disease
Remicade
Start date: 2002-10-04
Page 1 Next >>
|
